OMEGA PHARMA INNOVATION & DEVELOPMENT

{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-06-08",
    "filing_date": "2026-05-29",
    "act_kind_objet": "NEERLEGGING TER GRIFFIE"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "date": "2026-05-20",
    "unanimous": true
  },
  "agm_change": null,
  "detected_kind": "officer_designation",
  "other_address": null,
  "mandate_renewal": {
    "period_end": null,
    "mandate_kind": "bestuurder",
    "period_start": "2026-05-22",
    "remuneration_eur": null,
    "remuneration_kind": "gratuit",
    "person_or_entity_kbo": null,
    "person_or_entity_name": "Jonas Dhaenens"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV",
    "legal_form": "NV"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Charlotte Van Weehaeghe",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "Bijlagen bij het Belgisch Staatsblad - 08/06/2026"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": {
    "role": "bestuurder",
    "organ": "raad_van_bestuur",
    "person_name": "Jonas Dhaenens"
  },
  "special_procuration": {
    "grantee_kbo": null,
    "grantee_name": "Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters",
    "grantor_name": "Omega Pharma Innovation \u0026 Development NV",
    "scope_summary": "De enige aandeelhouder verleent een bijzondere volmacht aan bestuurders en een advocatenkantoor om de bijzondere verklaring in toepassing van artikel 13 van de wet van 4 mei 2023 op te stellen en te ondertekenen, deze beslissingen in het Belgisch Staatsblad te publiceren, en het dossier van de vennootschap bij de KBO aan te passen.",
    "monetary_cap_eur": null,
    "scope_categories": [
      "publication",
      "personnel",
      "other"
    ],
    "termination_clause": null,
    "substitution_allowed": true
  },
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anja van Winsberghe",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jonas Dhaenens",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anja van Winsberghe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2026-05-22",
      "evidence_quote": "De enige aandeelhouder beslist om. het mandaat van mevrouw Anja van Winsberghe als bestuurder van de Vennootschap te be\u00EBindigen met ingang vanaf 22 mei 2026. De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jonas Dhaenens",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2026-05-22",
      "evidence_quote": "De enige aandeelhouder beslist om de heer Jonas Dhaenens, met domicilie te Brandveld 29, 9500 Geraardsbergen, Belgi\u00EB, te benoemen als bestuurder van de Vennootschap met ingang vanaf 22 mei 2026."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "EY Bedrijfsrevisoren BV",
        "address": "Kouterveldstraat 7B, bus 1, 1831 Machelen",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-05-20",
      "evidence_quote": "De enige aandeelhouder neemt kennis van het ontslag van de commissaris van de Vennootschap, EY Bedrijfsrevisoren BV, met zetel te Kouterveldstraat 7B, bus 1, 1831 Machelen, vast vertegenwoordigd door de heer Paul Eelen, vertegenwoordiger van Paul Eelen BV, met ingang vanaf 20 mei 2025.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "EY Bedrijfsrevisoren BV",
        "address": "Kouterveldstraat 7B, bus 1, 1831 Machelen",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-05-20",
      "evidence_quote": "De enige aandeelhouder beslist om aan de commissaris kwijting te verlenen voor de uitoefening van diens mandaat tot 20 mei 2025.",
      "decharge_status": "granted",
      "mandate_duration": {
        "kind": "until_date",
        "value": "2025-05-20"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO Bedrijfsrevisoren BV",
        "address": "Elsinore Building - Corporate Village, Da Vincilaan 9, bus E.6, 1930 Zaventem",
        "birth_date": null,
        "profession": "bedrijfsrevisor",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "BDO Bedrijfsrevisoren BV",
        "address": "Elsinore Building - Corporate Village, Da Vincilaan 9, bus E.6, 1930 Zaventem",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-05-20",
      "evidence_quote": "De enige aandeelhouder beslist om BDO Bedrijfsrevisoren BV, met zetel te Elsinore Building - Corporate Village, Da Vincilaan 9, bus E.6, 1930 Zaventem, vast vertegenwoordigd door Evy Borry, bedrijfsrevisor, te benoemen als commissaris van de Vennootschap, met ingang vanaf 20 mei 2025, waarbij het ma",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2027"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bart Bellen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ine Schockaert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Charlotte Van Weehaeghe",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marthe Wouters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "contrast",
        "address": "Minervastraat 5, 1930 Zaventem",
        "birth_date": null,
        "profession": "advocaat",
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "advocaat",
        "address": null,
        "birth_date": null,
        "profession": "advocaat",
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "medewerker",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamen",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "mandate_termination_de_plein_droit",
      "role": "commissaris",
      "person": null,
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-12-22",
    "filing_date": "2025-05-20",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2025-05-20",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development",
    "legal_form": "NV",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Charlotte Van Weehaeghe",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzondere gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "EY Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Evy Borry",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BDO Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-05-20",
      "evidence_quote": "De enige aandeelhouder beslist om BDO Bedrijfsrevisoren BV, met zetel te Elsinore Building - Corporate Village, Da Vincilaan 9, bus E.6, 1930 Zaventem, vast vertegenwoordigd door Evy Borry, bedrijfsrevisor, te benoemen als commissaris van de Vennootschap, met ingang vanaf 20 mei 2025"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De enige aandeelhouder beslist om het mandaat van mevrouw Mira De Maeyer als bestuurder van de Vennootschap te be\u00EBindiging met ingang vanaf heden. De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De enige aandeelhouder beslist om mevrouw Sonia Hollies te benoemen als bestuurder van de Vennootschap met ingang vanaf heden."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De bestuurders beslissen om mevrouw Sonia Hollies te delegeren met het dagelijks bestuur van de Vennootschap en haar te benoemen als gedelegeerd bestuurder van de Vennootschap met ingang vanaf heden."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om het mandaat van mevrouw Mira De Maeyer als bestuurder van de Vennootschap te be\u00EBindiging met ingang vanaf heden. De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om mevrouw Sonia Hollies te benoemen als bestuurder van Vennootschap met ingang vanaf heden. Het mandaat van mevrouw Sonia Hollies zal eindigen op datum van de jaarvergadering die zal worden gehouden in het jaar 2030. Het bestuursmandaat zal onbezoldigd worden uitgeoef",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "De bestuurders beslissen om mevrouw Sonia Hollies te delegeren met het dagelijks bestuur van de Vennootschap en haar te benoemen als gedelegeerd bestuurder van de Vennootschap met ingang vanaf heden.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "De bestuurders beslissen om mevrouw Sonia Hollies te delegeren met het dagelijks bestuur van de Vennootschap en haar te benoemen als gedelegeerd bestuurder van de Vennootschap met ingang vanaf heden.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-10-15",
    "filing_date": "2024-08-29",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2024-08-29",
      "unanimous": null
    },
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2024-08-29",
      "unanimous": null
    },
    {
      "body": "raad_van_bestuur",
      "date": "2024-08-29",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "contrast",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Eelen",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BV EY Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De enige aandeelhouder herbenoemt tot commissaris voor een periode van drie jaar de BV EY Bedrijfsrevisoren (B00160), met maatschappelijke zetel te 1831 Machelen, Kouterveldstraat 7B, bus 1, die overeenkomstig artikel 3:58 van het Wetboek van Vennootschappen en Verenigingen als vertegenwoordiger aan"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BV EY Bedrijfsrevisoren (B00160)",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Gent",
        "region": "Vlaams Gewest",
        "street": "Gaston Crommenlaan",
        "country": "BE",
        "postcode": "9050",
        "box_number": "606",
        "street_number": "6"
      },
      "old_address": {
        "city": "Nazareth",
        "region": "Vlaams Gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26"
      },
      "effective_date": "2024-04-15",
      "evidence_quote": "Conform artikel 2 van de statuten besluit de raad van bestuur om de zetel van de Vennootschap verplaatsen naar 9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B, met ingang van 15 april 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_administratif",
      "new_address": {
        "raw": "9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B",
        "city": "Gent",
        "region": "vlaams_gewest",
        "street": "Gaston Crommenlaan",
        "country": "BE",
        "postcode": "9050",
        "box_number": "606",
        "street_number": "6",
        "locality_suffix": "(Ledeberg)"
      },
      "old_address": {
        "raw": "Venecoweg 26, 9810 Nazareth",
        "city": "Nazareth",
        "region": "vlaams_gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26",
        "locality_suffix": null
      },
      "effective_date": "2024-04-15",
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": 2,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    },
    {
      "kind": "zetel_clause_amendment_no_move",
      "seat_type": "unite_exploitation",
      "new_address": null,
      "old_address": {
        "raw": "Venecoweg 26, 9810 Nazareth",
        "city": "Nazareth",
        "region": "vlaams_gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26",
        "locality_suffix": null
      },
      "effective_date": "2024-04-15",
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2024-03-05",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2024-03-04",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Develoment NV",
    "legal_form": "NV",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nele Desutter",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzondere volmachtdrager"
  },
  "co_filed_documents": [
    "Bijlagen bij het Belgisch Staatsblad",
    "Annexes du Moniteur belge"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B",
        "city": "Gent (Ledeberg)",
        "region": "vlaams_gewest",
        "street": "Gaston Crommenlaan",
        "country": "BE",
        "postcode": "9050",
        "box_number": "606",
        "street_number": "6",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Venecoweg 26, 9810 Nazareth",
        "city": "Nazareth",
        "region": "vlaams_gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26",
        "locality_suffix": null
      },
      "effective_date": "2024-04-15",
      "evidence_quote": "Conform artikel 2 van de statuten besluit de raad van bestuur om de zetel van de Vennootschap verplaatsen naar 9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B, met ingang van 15 april 2024.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": "Conform artikel 2 van de statuten besluit de raad van bestuur om de zetel van de Vennootschap verplaatsen naar 9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B",
      "statute_article_number": "2",
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    },
    {
      "kind": "zetel_initial_set",
      "seat_type": "unite_exploitation",
      "new_address": {
        "raw": "Venecoweg 26, 9810 Nazareth",
        "city": "Nazareth",
        "region": "vlaams_gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": "2024-04-15",
      "evidence_quote": "Een uitbatingsetel van de Vennootschap blijft op de Venecoweg 26, 9810 Nazareth voor een periode van maximaal 5 jaar tot uiterlijk zondag 15 april 2029.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "inferred",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "future",
      "statutaire_vs_werkelijke": "werkelijke",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Notaris van de Ondernemingsrechtbank Gent, afdeling Gent",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2024-03-05",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2024-03-04",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Jennifer De Meyer",
    "org_rep_person_name": null,
    "person_role_at_subject": "bijzondere volmachtdrager"
  },
  "co_filed_documents": [
    "Uittreksel uit de notulen van de vergadering van de raad van bestuur",
    "Bijzondere volmacht aan Jennifer De Meyer en Nele Desutter"
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Pachtersbos BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-01-01",
      "evidence_quote": "De algemene vergadering benoemt tot bestuurder, met ingang 1 januari 2024, voor een periode van 6 jaar, Mira De Maeyer, wonende te 1700 Dilbeek, Rondebosstraat 80."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Magali Verbraeken",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Magali Verbraeken",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-01-23",
      "evidence_quote": "De algemene vergadering benoemt Magali Verbraeken, wonende te Scheldeveldestraat 27, 9840 De Pinte, als bestuurder van de Vennootschap, met ingang van heden, voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Magali Verbraeken",
        "address": "Scheldeveldestraat 27, 9840 De Pinte",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": "2023-02-23",
      "evidence_quote": "De algemene vergadering benoemt Magali Verbraeken, wonende te Scheldeveldestraat 27, 9840 De Pinte, als bestuurder van de Vennootschap, met ingang van heden, voor een periode van 6 jaar. Het mandaat is onbezoldigd.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Anouk Van Hecke",
        "address": "zetel van de vennootschap",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Een bijzondere volmacht wordt verleend, elk afzonderlijk, met recht van substitutie, aan Anouk Van Hecke, Jennifer De Meyer, Nele Desutter, allen woonplaats kiezende op de zetel van de vennootschap om alle administratieve formaliteiten te vervullen bij de bevoegde instanties zoals publicatie Belgisc",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Jennifer De Meyer",
        "address": "zetel van de vennootschap",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Een bijzondere volmacht wordt verleend, elk afzonderlijk, met recht van substitutie, aan Anouk Van Hecke, Jennifer De Meyer, Nele Desutter, allen woonplaats kiezende op de zetel van de vennootschap om alle administratieve formaliteiten te vervullen bij de bevoegde instanties zoals publicatie Belgisc",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Nele Desutter",
        "address": "zetel van de vennootschap",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Een bijzondere volmacht wordt verleend, elk afzonderlijk, met recht van substitutie, aan Anouk Van Hecke, Jennifer De Meyer, Nele Desutter, allen woonplaats kiezende op de zetel van de vennootschap om alle administratieve formaliteiten te vervullen bij de bevoegde instanties zoals publicatie Belgisc",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2023-02-20",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-01-23",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Develoment NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nele Desutter",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzondere volmachtdrager"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": "Via Arzaga 30, 20124 Milaan",
        "birth_date": null,
        "profession": null,
        "birth_place": "Milaan, Itali\u00EB"
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2022-12-22",
      "evidence_quote": "De algemene vergadering neemt kennis van het ontslag van Gianluca Parola, wonende te Itali\u00EB, 20124 Milaan, Via Arzaga 30, als bestuurder van de Vennootschap, met ingang van heden.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": "Via Arzaga 30, 20124 Milaan",
        "birth_date": null,
        "profession": null,
        "birth_place": "Milaan, Itali\u00EB"
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering dankt Gianluca Parola voor haar inzet voor de Vennootschap.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2022-12-22",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2022-12-01",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Develoment NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nele Desutter",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzondere volmachtdrager"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-07-29",
      "evidence_quote": "De algemene vergadering benoemt, met ingang van heden, Gianluca Parola, wonende te Itali\u00EB, 20124 Milaan, Via Arzaga 30, tot bestuurder voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patrick O\u0027Sullivan",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Bruno Raes",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Kortrijk",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-09-02",
    "filing_date": "2021-08-25",
    "act_kind_objet": "Met parti\u00EBle splitsing door overneming gelijkgestelde verrichting -"
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2021-07-23",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": {
    "summary": "De aandeelhouders van de betrokken vennootschappen hebben uitdrukkelijk afstand gedaan van het opstellen van de splitsingsverslagen van de bestuursorganen en commissaris, en van de overige formaliteiten vermeld in de artikelen 12:61, 12:62 en 12:64 van het Wetboek van vennootschappen en verenigingen",
    "articles": [
      "12:62 \u00A71",
      "12:65",
      "12:61",
      "12:64"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0884.084.724",
        "name": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT",
        "role": "demerged",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0431.676.229",
        "name": "Perrigo Holding",
        "role": "recipient",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:62 \u00A71",
      "12:65",
      "12:8",
      "12:61",
      "12:64",
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2021-07-23",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": true,
    "patrimony_description": "Een deel van het activa en passiva van OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT werd overgedragen aan Perrigo Holding. De overdracht betrof een bedrijfstak, inclusief roerend en onroerend vermogen, gericht op farmaceutische en parapharmaceutische producten, ontwikkeling, verkoop en intellectuele eigendom.",
    "equity_transferred_eur": 4321426.39,
    "accounting_effective_date": "2021-07-23"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Bruno Raes",
    "org_rep_person_name": null
  },
  "summary_narrative": "De naamloze vennootschap OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT werd op 23 juli 2021 partiel gesplitst door overdracht van een deel van haar activa en passiva naar Perrigo Holding, gevestigd op dezelfde locatie. De splitsing was geruisloos en gebeurde zonder uitgifte van nieuwe aandelen. Het kapitaal werd verminderd met \u20AC4.321.426,39. De statuten werden herformuleerd en aangepast aan het Wetboek van vennootschappen en verenigingen. De vergadering verleende bijzondere volmachten aan vier vrouwen om de administratieve formaliteiten te vervullen.",
  "co_filed_documents": [
    "expeditie van het proces-verbaal van met parti\u00EBle splitsing door overneming gelijkgestelde verrichting en statutenwijziging",
    "3 volmachten, aangehecht",
    "geco\u00F6rdineerde tekst van de statuten"
  ],
  "detected_real_type": "demerger_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 4321426.39,
      "currency": "EUR",
      "after_eur": 3951073.61,
      "delta_eur": -4321426.39,
      "before_eur": 8272500.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-07-23",
      "evidence_quote": "het kapitaal van de vennootschap verminderd werd met vier miljoen driehonderdeenentwintigduizend vierhonderdzesentwintig euro negenendertig cent (\u20AC 4.321.426,39) om het kapitaal te brengen van acht miljoen tweehonderdtwee\u00EBnzeventigduizend vijfhonderd euro (\u20AC 8.272.500,00) op drie miljoen negenhonderdeenenvijftigduizend drie\u00EBnzeventig euro \u00E9\u00E9nenzestig cent (\u20AC 3.951.073,61)",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 3951073.61,
      "delta_eur": -4321426.390000001,
      "before_eur": 8272500.0,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-08-25",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Nele DESUTTER",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Jennifer DE MEYER",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Anja VAN WINSBERGHE",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Anouk VAN HECKE",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Anja Van Winsberghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-06-17",
    "filing_date": "2021-06-09",
    "act_kind_objet": "Voorstel tot geruisloze parti\u00EBle splitsing"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2021-05-26",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0884.084.724",
        "name": "Omega Pharma Innovation \u0026 Development NV",
        "role": "demerged",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0431.676.229",
        "name": "Perrigo Holding NV",
        "role": "recipient",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:8, 2\u00B0",
      "12:59"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2020-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De overdracht betreft een gedeelte van het vermogen van Omega Pharma Innovation \u0026 Development NV, met name aandelen in tien dochterondernemingen (waaronder Perrigo Pharma Holding Netherlands BV, Perrigo Italia Srl, Perrigo Espa\u00F1a SA, etc.) en de bijbehorende passiva. De activa en passiva worden overgedragen op basis van de jaarrekening afgesloten per 31 december 2020.",
    "equity_transferred_eur": 370815430.62,
    "accounting_effective_date": "2021-01-01"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Anja Van Winsberghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Omega Pharma Innovation \u0026 Development NV en Perrigo Holding NV stellen voor om een geruisloze parti\u00EBle splitsing uit te voeren, waarbij een gedeelte van het vermogen van Omega Pharma Innovation \u0026 Development NV \u2014 met name aandelen in diverse dochterondernemingen \u2014 wordt overgedragen naar Perrigo Holding NV. De splitsing is geruisloos, omdat de verkrijgende vennootschap reeds alle aandelen van de gesplitste vennootschap bezit. De overdracht is gebaseerd op de jaarrekening afgesloten per 31 december 2020 en wordt boekhoudkundig geacht vanaf 1 januari 2021 te zijn verricht",
  "co_filed_documents": [],
  "detected_real_type": "demerger_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}